ID   REV_CAEVC               Reviewed;         133 AA.
AC   P33460;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1994, sequence version 1.
DT   07-APR-2021, entry version 45.
DE   RecName: Full=Protein Rev;
DE   AltName: Full=Rev-C;
GN   Name=rev;
OS   Caprine arthritis encephalitis virus (strain Cork) (CAEV-Co).
OC   Viruses; Riboviria; Pararnavirae; Artverviricota; Revtraviricetes;
OC   Ortervirales; Retroviridae; Orthoretrovirinae; Lentivirus.
OX   NCBI_TaxID=11661;
OH   NCBI_TaxID=9925; Capra hircus (Goat).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RX   PubMed=2171210; DOI=10.1016/0042-6822(90)90303-9;
RA   Saltarelli M., Querat G., Konings D.A.M., Vigne R., Clements J.E.;
RT   "Nucleotide sequence and transcriptional analysis of molecular clones of
RT   CAEV which generate infectious virus.";
RL   Virology 179:347-364(1990).
RN   [2]
RP   RNA-BINDING, AND MUTAGENESIS OF LYS-13; GLU-14; ASN-15; VAL-19; THR-20;
RP   MET-21; 22-ASP--GLU-24; LYS-25; GLU-26; ARG-27; LYS-28; ARG-29;
RP   31-GLY--THR-23 AND 34-ALA--GLN-37.
RX   PubMed=12606073; DOI=10.1016/s0168-1702(02)00311-8;
RA   Abelson M.L., Schoborg R.V.;
RT   "Characterization of the caprine arthritis encephalitis virus (CAEV) rev N-
RT   terminal elements required for efficient interaction with the RRE.";
RL   Virus Res. 92:23-35(2003).
CC   -!- FUNCTION: Escorts unspliced or incompletely spliced viral pre-mRNAs
CC       (late transcripts) out of the nucleus of infected cells. These pre-
CC       mRNAs carry a recognition sequence called Rev responsive element (RRE)
CC       located in the env gene, that is not present in fully spliced viral
CC       mRNAs (early transcripts). This function is essential since most viral
CC       proteins are translated from unspliced or partially spliced pre-mRNAs
CC       which cannot exit the nucleus by the pathway used by fully processed
CC       cellular mRNAs (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Homomultimer; when bound to the RRE. Multimeric assembly is
CC       essential for activity (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Host nucleus, host nucleolus {ECO:0000250}. Host
CC       cytoplasm {ECO:0000250}. Note=The presence of both nuclear import and
CC       nuclear export signals leads to continuous shuttling between the
CC       nucleus and cytoplasm. {ECO:0000250}.
CC   -!- DOMAIN: The RNA-binding motif binds to the RRE present in incompletely
CC       spliced viral pre-mRNAs. This region also contains the NLS which
CC       mediates nuclear localization. These overlapping functions prevent Rev
CC       bound to RRE from undesirable return to the nucleus. When Rev binds the
CC       RRE, the NLS becomes masked while the NES remains accessible (By
CC       similarity). {ECO:0000250}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M33677; -; NOT_ANNOTATED_CDS; Genomic_RNA.
DR   PIR; F45345; F45345.
DR   Proteomes; UP000203242; Genome.
DR   GO; GO:0030430; C:host cell cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0044196; C:host cell nucleolus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003723; F:RNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0051028; P:mRNA transport; IEA:UniProtKB-KW.
PE   1: Evidence at protein level;
KW   Host cytoplasm; Host nucleus; mRNA transport; Reference proteome;
KW   RNA-binding; Transport.
FT   CHAIN           1..133
FT                   /note="Protein Rev"
FT                   /id="PRO_0000085475"
FT   REGION          13..27
FT                   /note="RNA-binding (RRE)"
FT   MOTIF           59..82
FT                   /note="Nuclear localization signal and RNA-binding (RRE)"
FT                   /evidence="ECO:0000250"
FT   MOTIF           89..102
FT                   /note="Nuclear export signal"
FT                   /evidence="ECO:0000250"
FT   MUTAGEN         13
FT                   /note="K->A: Almost complete loss of RRE-binding."
FT                   /evidence="ECO:0000269|PubMed:12606073"
FT   MUTAGEN         14
FT                   /note="E->A: Almost complete loss of RRE-binding."
FT                   /evidence="ECO:0000269|PubMed:12606073"
FT   MUTAGEN         15
FT                   /note="N->A: Almost complete loss of RRE-binding."
FT                   /evidence="ECO:0000269|PubMed:12606073"
FT   MUTAGEN         19
FT                   /note="V->A: Partial loss of RRE-binding."
FT                   /evidence="ECO:0000269|PubMed:12606073"
FT   MUTAGEN         20
FT                   /note="T->A: Almost complete loss of RRE-binding."
FT                   /evidence="ECO:0000269|PubMed:12606073"
FT   MUTAGEN         21
FT                   /note="M->A: Almost complete loss of RRE-binding."
FT                   /evidence="ECO:0000269|PubMed:12606073"
FT   MUTAGEN         22..24
FT                   /note="DGE->AAA: Slight loss of RRE-binding."
FT                   /evidence="ECO:0000269|PubMed:12606073"
FT   MUTAGEN         25
FT                   /note="K->A: Slight loss of RRE-binding."
FT                   /evidence="ECO:0000269|PubMed:12606073"
FT   MUTAGEN         26
FT                   /note="E->A: Slight loss of RRE-binding."
FT                   /evidence="ECO:0000269|PubMed:12606073"
FT   MUTAGEN         27
FT                   /note="R->A: Partial loss of RRE-binding."
FT                   /evidence="ECO:0000269|PubMed:12606073"
FT   MUTAGEN         28
FT                   /note="K->A: No loss of RRE-binding."
FT                   /evidence="ECO:0000269|PubMed:12606073"
FT   MUTAGEN         29
FT                   /note="R->A: No loss of RRE-binding."
FT                   /evidence="ECO:0000269|PubMed:12606073"
FT   MUTAGEN         31..33
FT                   /note="GFT->AAA: No loss of RRE-binding."
FT   MUTAGEN         34..37
FT                   /note="AGQQ->GAAA: Slight loss of RRE-binding."
FT                   /evidence="ECO:0000269|PubMed:12606073"
SQ   SEQUENCE   133 AA;  15283 MW;  127DFB5B0002D44E CRC64;
     MDAGARYMRL TGKENWVEVT MDGEKERKRE GFTAGQQDIQ NSKYPDIPTG HSHHGNKSRR
     RRRKSGFWRW LRGIRQQRNK RKSDSTESLE PCLGALAELT LEGAMEKGPA EAARPSADDG
     NLDKWMAWRT PQK
//
